FDA Adverse Event Other Summary report: N

NANOKNIFE SINGLE ELECTRODE PROBE, 15CM

MDR report key: 2110076 · Received May 19, 2011

Report

Report Number
1319211-2011-00038
Event Type
Other
Date Received
May 19, 2011
Date of Event
June 30, 2010
Report Date
May 19, 2011
Manufacturer
ANGIODYNAMICS
Product Code
GEI
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS REPORT IS NOT BEING SENT FOR A PRODUCT PROBLEM. THERE WAS NO INDICATION THAT THE DEVICE MALFUNCTIONED. THIS REPORT IS BEING SUBMITTED TO NOTIFY THE FDA THAT MEDICAL INTERVENTION WAS REQUIRED, IN THE FORM OF .5MG CARDENE IV (CA+ CHANNEL BLOCKER), DURING THE PROCEDURE. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITHOUT FURTHER ISSUES. NO HARM OR INJURY WAS REPORTED TO THE PATIENT. THIS MEDWATCH IS BEING SUBMITTED LATE DUE TO A RETROSPECTIVE REVIEW OF CASE NOTES. (B)(4).

Description of Event or Problem · 1

DURING A LAPAROTOMY WITH ULTRASOUND GUIDED NANOKNIFE ABLATION, THE PATIENT'S BLOOD PRESSURE AT BASELINE WAS APPROXIMATELY 120. WITHIN THE FIRST MINUTE OF PULSE GENERATION, THE PATIENT'S BLOOD PRESSURE BEGAN TO INCREASE, INDICATING HYPERTENSION. WHEN BLOOD PRESSURE WAS NOTED AT 190/114, THE PHYSICIAN ADVISED THAT PULSE GENERATION BE SUSPENDED. THE ANESTHESIOLOGIST GAVE 0.5MG CARDENE IV (CA+ CHANNEL BLOCKER) AND PATIENT'S BLOOD PRESSURE BEGAN TO NORMALIZE WITHIN 90 SECONDS OF ADMINISTRATION. WITH THE PATIENT'S BLOOD PRESSURE AT 112/63, THE PHYSICIAN ELECTED TO RESTART PULSE GENERATION. THE PATIENT'S BLOOD PRESSURE BEGAN TO INCREASE AGAIN INTO THE 150'S DURING PULSE GENERATION AND A SECOND DOSE OF CARDENE 0.5MG IV WAS ADMINISTERED. THE PATIENT'S BLOOD PRESSURE THEN REMAINED STABLE THROUGHOUT THE REST OF CASE. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITHOUT FURTHER ISSUES. NO HARM OR INJURY WAS REPORTED TO THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 NANOKNIFE SINGLE ELECTRODE PROBE, 15CM TISSUE ABLATION DEVICE GEI ANGIODYNAMICS NA NOT REPORTED

Patients

Seq Age Sex Outcome Treatment
1 70 YR Required Intervention